AKYNZEO (Helsinn Therapeutics (U.S.), Inc.)
Welcome to the PulseAid listing for the AKYNZEO drug offered from Helsinn Therapeutics (U.S.), Inc.. This Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Helsinn Therapeutics (U.S.), Inc. |
| NON-PROPRIETARY NAME: | Netupitant and Palonosetron |
| SUBSTANCE NAME: | NETUPITANT; PALONOSETRON |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-10-13 |
| END MARKETING DATE: | 0000-00-00 |
AKYNZEO HUMAN PRESCRIPTION DRUG Details:
| Item Description | AKYNZEO from Helsinn Therapeutics (U.S.), Inc. |
| LABELER NAME: | Helsinn Therapeutics (U.S.), Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300; .5(mg/1; mg/1) |
| START MARKETING DATE: | 2014-10-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69639-101_b92142f8-32ea-428d-8a2e-ce59482b8bd6 |
| PRODUCT NDC: | 69639-101 |
| APPLICATION NUMBER: | NDA205718 |
Other NETUPITANT; PALONOSETRON Pharmaceutical Manufacturers / Labelers:
